A Possible Relationship Between Vitamin D Levels and Colon and Rectal Cancer in Women

Results from a large observational study showed a relationship between blood vitamin D levels and women’s colorectal (large bowel) cancer risk. These results were published in Cancer Epidemiology, Biomarkers & Prevention .
Previous observational studies examining levels of 25-hydroxyvitamin D [25 (OH) D] in plasma or serum samples had provided some support for an association between high vitamin D levels and lower colorectal cancer risk. Results for breast and prostate cancer risk were conflicting.
This study was part of the Melbourne Collaborative Cohort Study, launched in the early 1990s to follow healthy adults in Australia and prospectively (forward-looking) assess the effects of diet and lifestyle on the development of non-communicable diseases.
From a baseline group of 29.205 participants without a cancer diagnosis, a random subgroup of 1332 women and 1664 men was selected. Cases included participants diagnosed with colorectal, breast, or prostate cancer through December 2007. The analysis included 547 colorectal, 634 breast, and 824 prostate cancer cases.
The study’s most important finding was an inverse association between high blood vitamin D levels and colorectal cancer risk in women: %48 risk reduction. However, observing such a risk reduction in men.
Interestingly, in people with high D levels, BRAF V600E-mutant colorectal cancer risk was % 29 lower. This mutation is positive in approximately %10 of colon and rectal cancers.
No significant relationship was observed between blood vitamin D levels and breast or prostate cancer risk, estrogen receptor status (breast), stage, or KRAS status (in colorectal cancer).
Note: This study provides results confirming an association between blood vitamin D levels and colorectal cancer in women, but these results alone cannot establish a cause-and-effect relationship. In other words, we cannot say that taking vitamin D supplements protects women against colorectal cancer, because there may be other reasons why women with less colorectal cancer have higher vitamin D levels, and this study does not reveal those reasons or establish a clear causal relationship.
Sources
Circulating 25-hydroxyvitamin D concentration and risk of breast, prostate, and colorectal cancers: the Melbourne Collaborative Cohort Study.
Cancer Epidemiol Biomarkers Prev, 6 March 2019.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.